Charles River Laboratories Acquires KWS BioTest

Acquisitions

▤ Summary

Charles River Laboratories is acquiring KWS BioTest. This is a strategic move in the life sciences services and research market. The article text itself is blocked, so only the headline is available for context. The deal may expand Charles River’s capabilities and customer offering in preclinical and bioanalysis-related services.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies